ALIVUS
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹641.8 Cr | ₹602.5 Cr | ₹601.8 Cr | ₹672.9 Cr |
| Net Profit | ₹137 Cr | ₹141.9 Cr | ₹121.5 Cr | ₹150.3 Cr |
| EPS | ₹11.18 | — | ₹9.91 | ₹12.25 |
| Operating Profit | ₹200.8 Cr | ₹208.5 Cr | ₹181.3 Cr | ₹219.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 01 Sept 2025 | Dividend - Rs 5 Per Share | DIVIDEND |
| 17 Oct 2023 | Interim Dividend - Rs 22.50 Per Share | INTERIM_DIVIDEND |
| 22 Sept 2023 | Annual General Meeting | AGM |
| 24 Mar 2023 | Interim Dividend - Rs 21 Per Share | INTERIM_DIVIDEND |
| 15 Sept 2022 | Dividend - Rs 10.5 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ALIVUS
View All
Anupam Rasayan becomes world's first to make ETFA using flow chemistry
Anupam Rasayan India Ltd has achieved a global first by commercialising Ethyl trifluoroacetate production using its unique continuous flow chemistry technology. This advanced method offers enhanced safety and efficiency over traditional batch processes. ETFA is a vital component for pharmaceuticals and life sciences.
Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone
Anupam Rasayan India announces commercialization of ETFA production via a proprietary continuous flow chemistry platform, making it the first globally to do so. The market potential for ETFA is $500-600 million, crucial for fluorinated compounds in pharmaceuticals and life sciences.
Analysts project up to 17% upside in healthcare stocks trading at new highs
Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.